Our aim is to support the discovery of a safe, affordable, scalable and effective cure, available to all persons living with CHB including children. To reach this goal, our vision is to create an international, independent, research-based and patient-centered forum in order to coordinate, promote and foster collaborative partnerships working towards a cure for HBV.

What we do

To advance HBV cure research we created international working groups on virology, immunology, innovative tools and clinical studies to identify research gaps needed to be addressed for an HBV Cure and perform the research needed to address these gaps.

We collaborate with key stakeholders, including patient representatives, research agencies, global health organisations, foundations and pharmaceutical industry to accelerate research in HBV cure.

HBV Prevention, Care, Treatment and Cure

ICE-HBV supports the Global Health Sector Strategy on Viral Hepatitis (WHO, 2016). By no means should the strengthening of HBV cure research direct resources away from HBV prevention, care and treatment programmes. However, the HBV scientific community believes that government, foundations and other research sponsors should make a substantial investment in HBV cure research now. HBV research has been largely underfunded compared to other diseases; enhanced investments could make a big difference and create important resources savings within 10 years. Coupled with the implementation of the 2016 Global Health Sector Strategy on Viral Hepatitis, an HBV cure could help fully eradicate HBV thus saving millions of lives.